Comparing Ansell (ANSLF) & Its Rivals

Posted by MarketBeat News on Sep 8th, 2023

Ansell (OTCMKTS:ANSLF – Get Free Report) is one of 66 publicly-traded companies in the “Medical Instruments & Supplies” industry, but how does it weigh in compared to its peers? We will compare Ansell to similar businesses based on the strength of its institutional ownership, profitability, risk, earnings, analyst recommendations, valuation and dividends.

Dividends

Ansell pays an annual dividend of $0.40 per share and has a dividend yield of 2.7%. Ansell pays out 130.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Medical Instruments & Supplies” companies pay a dividend yield of 2.4% and pay out 32.0% of their earnings in the form of a dividend.

Institutional & Insider Ownership

39.0% of Ansell shares are owned by institutional investors. Comparatively, 32.7% of shares of all “Medical Instruments & Supplies” companies are owned by institutional investors. 30.6% of shares of all “Medical Instruments & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Valuation and Earnings

Want More Great Investing Ideas?

This table compares Ansell and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue	Net Income	Price/Earnings Ratio
Ansell	N/A	N/A	48.66
Ansell Competitors	$1.06 billion	$143.79 million	522.38

Ansell’s peers have higher revenue and earnings than Ansell. Ansell is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Ansell and its peers’ net margins, return on equity and return on assets.

Net Margins	Return on Equity	Return on Assets
Ansell	N/A	N/A	N/A
Ansell Competitors	-9.50%	1.97%	1.86%

Analyst Ratings

This is a breakdown of current ratings and price targets for Ansell and its peers, as provided by MarketBeat.com.

Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ansell	0	0	0	0	N/A
Ansell Competitors	259	810	764	12	2.29

As a group, “Medical Instruments & Supplies” companies have a potential upside of 28.01%. Given Ansell’s peers higher possible upside, analysts plainly believe Ansell has less favorable growth aspects than its peers.

Summary

Ansell peers beat Ansell on 7 of the 10 factors compared.

Ansell Company Profile

(Get Free Report)

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.

Receive News & Ratings for Ansell Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ansell and related companies with MarketBeat.com's FREE daily email newsletter.